The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Activity of chemotherapy in a series of patients with locally advanced or metastatic pleomorphic rhabdomyosarcoma: A retrospective analysis.
Michela Libertini
Research Funding - PharmaMar
Nadia Hindi
No relevant relationships to disclose
Salvatore Provenzano
Research Funding - PharmaMar
Rossella Bertulli
Research Funding - PharmaMar
Roberta Sanfilippo
Research Funding - PharmaMar
Silvia Stacchiotti
Research Funding - PharmaMar
Elena Palassini
Research Funding - PharmaMar
Elena Fumagalli
Research Funding - PharmaMar
Giacomo G. Baldi
No relevant relationships to disclose
Bruno Vincenzi
No relevant relationships to disclose
Angelo Paolo Dei Tos
Consultant or Advisory Role - PharmaMar
Alessandro Gronchi
No relevant relationships to disclose
Paolo Giovanni Casali
Consultant or Advisory Role - PharmaMar (U)
Honoraria - PharmaMar
Research Funding - PharmaMar
Other Remuneration - PharmaMar